As a result, shares of the company jumped 10.17 percent to Rs 7,000 on BSE. On NSE, the stock rose 10.19 percent to Rs 6,998. CFTRI had tested five samples sent by the Goa Food and Drug Administration (FDA) when Maggi was banned in June in the wake of findings in Uttar Pradesh and other states that the instant noodles brand had lead levels beyond permissible limits.

"The CFTRI finding shows that samples are in compliance with the food safety standards as per the Food Safety and Standards Rules, 2011," Goa FDA Director Salim A Veljee told reporters. In June this year, Nestle had to take Maggi off the shelves after a few states decided to ban the noodles.

Latest News  from Business News Desk